Thapsigargin ≥99% (durch HPLC)

Lieferant: ENZO LIFE SCIENCES AG

ENZOBMLPE1800005EA 423 CHF
ENZOBMLPE1800005 ENZOBMLPE1800001
Thapsigargin ≥99% (durch HPLC)
Thapsigargin

ATPase inhibitor


Cell permeable tumor promoter. Induces the release of intracellular stored Ca2+ without hydrolysis of inositolphospholipids via inhibition of the (sarco)endoplasmatic reticulum Ca2+-ATPase (SERCA) (IC50=30nM). Inhibition of SERCA reveals a significant change in intracellular Ca2+ homeostasis and pH regulation in tumor cells. May be used to distinguish between discrete intracellular Ca2+ pools. Thapsigargin-induced tumor promotion and down regulation of the EGF receptor is independent of PKC activation. Increases Ca2+-dependent Na+ influx in human platelets in a dose-dependent manner. Induces apoptosis. Stimulates nitric oxide (NO) production, contributing to hepatocyte apoptosis.

Formel: C₃₄H₅₀O₁₂
MW: 650,762 g/mol
MDL Number: MFCD00083511
CAS-Nummer: 67526-95-8

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR